Bayer logo

Bayer

BAYRY | OTC
Chart Builder DCF Calculator
$15.61
-$0.05 (-0.32%)
At close: Nov 16, 2026, 3:59 PM ET
$15.60
-$0.01 (-0.06%)
After-hours: Nov 16, 2026, 4:00 PM ET
-0.32%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
28.1
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #852/1021 (Top 83%)

Why Price Moved

7 days ago
+3.78%

Shares are trading higher following U.S. approval ...

Key Statistics

Market Data

Market Cap $61.34B
1D Range
15.59 15.80
52W Range
7.68 15.98

Valuation (TTM)

PE -36.56
PB 1.86
EV/EBITDA 6.93

Valuation (NTM)

Forward PE 12.37
Forward PEG 12.89
Price Target $0.00
Loading financial charts...

Profile

Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into ...

Sector Healthcare
Employees 88,078
IPO Date Nov 18, 1996
Fiscal Year n/a

Latest News

Bayer Wins FDA Approval for Sunharbo for Secondary Stroke Risk Reduction

6 days ago · zacks.com

Bayer Wins FDA Approval for Sunharbo for Secondary Stroke Risk Reduction
Bayer's SUNHARBO® (asundexian), 50 mg tablets, the First and Only Factor XIa Inhibitor, Approved by the U.S.

7 days ago · businesswire.com

Bayer's SUNHARBO® (asundexian), 50 mg tablets, the First and Only Factor XIa Inhibitor, Approved by the U.S.
3 Large-Cap Stocks to Watch as Drug & Biotech Sector Rebounds in 2026

8 days ago · zacks.com

3 Large-Cap Stocks to Watch as Drug & Biotech Sector Rebounds in 2026
BAYRY vs. JNJ: Which Stock Is the Better Value Option?

12 days ago · zacks.com

BAYRY vs. JNJ: Which Stock Is the Better Value Option?
Are Medical Stocks Lagging Bayer (BAYRY) This Year?

12 days ago · zacks.com

Are Medical Stocks Lagging Bayer (BAYRY) This Year?
Bayer and America's Grow-a-Row Continue Partnership to Fight Food Insecurity

13 days ago · businesswire.com

Bayer and America's Grow-a-Row Continue Partnership to Fight Food Insecurity
Bayer seeks bigger role in fast-growing Latin American biologicals market

13 days ago · reuters.com

Bayer seeks bigger role in fast-growing Latin American biologicals market
BAYRY Q3 Earnings and Revenues Miss Estimates, Pharma Performs Well

13 days ago · zacks.com

BAYRY Q3 Earnings and Revenues Miss Estimates, Pharma Performs Well
Bayer to Present New Cardiovascular, Kidney and Stroke Data at the 2026 American Heart Association (AHA) Scientific Sessions

13 days ago · businesswire.com

Bayer to Present New Cardiovascular, Kidney and Stroke Data at the 2026 American Heart Association (AHA) Scientific Sessions
Bayer AG: Solid Q3 Earnings, But Still A 'Prove-It' Story

13 days ago · seekingalpha.com

Bayer AG: Solid Q3 Earnings, But Still A 'Prove-It' Story

Earnings

Latest Earnings
Nov 3, 2026
EPS
$0.09
Miss -30.77%
REV
$11.25B
Beat +0.36%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.